Moderna (MRNA) Beats on Q2 Earnings, Starts $3B Buyback Program

This article was originally published on Nasdaq

Moderna, Inc. MRNA reported earnings of $5.24 per share for the second quarter of 2022, beating the Zacks Consensus Estimate of $4.45. The company had reported earnings of $6.46 per share in the year-ago quarter. The year-over-year decline in the bottom line was due to hi